KETOPROFEN - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ketoprofen and what is the scope of freedom to operate?
Ketoprofen
is the generic ingredient in six branded drugs marketed by Actavis Labs Fl Inc, Alkermes Gainesville, Mylan, Wyeth Pharms Inc, Misemer, Rising, Teva, Wyeth Ayerst, Novartis, Bayer, Perrigo, and Wyeth Cons, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-seven drug master file entries for ketoprofen. Five suppliers are listed for this compound.
Summary for KETOPROFEN
US Patents: | 0 |
Tradenames: | 6 |
Applicants: | 12 |
NDAs: | 15 |
Drug Master File Entries: | 27 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 166 |
Clinical Trials: | 98 |
Patent Applications: | 7,221 |
Drug Prices: | Drug price trends for KETOPROFEN |
Drug Sales Revenues: | Drug sales revenues for KETOPROFEN |
What excipients (inactive ingredients) are in KETOPROFEN? | KETOPROFEN excipients list |
DailyMed Link: | KETOPROFEN at DailyMed |
Recent Clinical Trials for KETOPROFEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Osteology Foundation | Phase 4 |
University of Iowa | Phase 4 |
Gustavo Avila-Ortiz DDS, MS, PhD | Phase 4 |
Pharmacology for KETOPROFEN
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for KETOPROFEN
Anatomical Therapeutic Chemical (ATC) Classes for KETOPROFEN
US Patents and Regulatory Information for KETOPROFEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | KETOPROFEN | ketoprofen | CAPSULE;ORAL | 074035-002 | Dec 31, 1996 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Rising | KETOPROFEN | ketoprofen | CAPSULE;ORAL | 074024-001 | Dec 29, 1995 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Alkermes Gainesville | KETOPROFEN | ketoprofen | CAPSULE, EXTENDED RELEASE;ORAL | 074879-001 | Dec 10, 1997 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Wyeth Ayerst | ORUDIS | ketoprofen | CAPSULE;ORAL | 018754-001 | Jul 31, 1987 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for KETOPROFEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Ayerst | ORUDIS | ketoprofen | CAPSULE;ORAL | 018754-001 | Jul 31, 1987 | 3,641,127 | ⤷ Subscribe |
Wyeth Ayerst | ORUDIS | ketoprofen | CAPSULE;ORAL | 018754-003 | Jan 9, 1986 | 3,641,127 | ⤷ Subscribe |
Wyeth Ayerst | ORUDIS | ketoprofen | CAPSULE;ORAL | 018754-002 | Jan 9, 1986 | 3,641,127 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
KETOPROFEN Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.